A programme meant to allow pharmacists and nurses working at private pharmacies to prescribe HIV treatment or anti-HIV pills and jabs is on hold because of a drawn-out court case
CAB-LA will be made at Indian drug company Cipla’s Benoni and Durban plants, but a starting date for production has not yet been announced
But for how much will drugmaker ViiV Healthcare sell it to the government? We asked them in our TV programme, Health Beat
A new HIV prevention medicine could work even better than daily pills but if nothing changes it costs more than R300 000 to treat one person for a year
The CAB-LA injection is the first of its kind in HIV prevention interventions and only needs to be taken every eight weeks